Viridis Chemicals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 04-07-2024
- Paid Up Capital ₹ 2.35 Cr
as on 04-07-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.72 Cr
as on 04-07-2024
- Revenue 851.97%
(FY 2023)
- Profit -392.29%
(FY 2023)
- Ebitda -104.57%
(FY 2023)
- Net Worth -14.58%
(FY 2023)
- Total Assets 3.51%
(FY 2023)
About Viridis Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.35 Cr.
The company currently has active open charges totaling ₹22.72 Cr.
Ajay Aggarwal, Anish Modi, Suparna Mandal, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24230MH2011PTC219148
- Company No.
219148
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jun 2011
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Viridis Chemicals?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suparna Mandal  | Director | 27-Jun-2011 | Current |
| Chaitanya Sampara | Director | 27-Jun-2011 | Current |
| Ajay Aggarwal | Director | 16-Aug-2018 | Current |
| Anish Modi | Director | 26-Feb-2018 | Current |
| Mukesh Sheth | Director | 16-Aug-2018 | Current |
| Manish Kirit | Director | 23-Aug-2018 | Current |
Financial Performance and Corporate Structure Insights of Viridis Chemicals.
Viridis Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 851.97% increase. The company also saw a substantial fall in profitability, with a 392.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Viridis Chemicals?
In 2023, Viridis Chemicals had a public holding of 45.95%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Industrial And Prudential Investment Company LimitedActive 111 years 3 monthsAnish Modi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Aug 2023 | ₹22.72 Cr | Open |
How Many Employees Work at Viridis Chemicals?
Unlock and access historical data on people associated with Viridis Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Viridis Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Viridis Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
